While attention has been on Apple’s progress (or lack thereof) in Research Triangle Park, the company continues to spend on a ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

Early results were shared during the Praxis scientific exhibit at the December 2024 American Epilepsy Society Annual Meeting, demonstrating significant disease burden compounded by persistent, ...

In December 2024, Praxis received Rare Pediatric Disease Designation (RPDD) from the U.S. Food and Drug Administration (FDA) for relutrigine for Dravet Syndrome. This is the third RPDD for relutrigine ...

MESA, Ariz.—Enrique Lopez votes sporadically but bought into Donald Trump’s vows to fight for everyday workers, helping the Republican flip Arizona last year. Then the home construction contractor ...

NewAmsterdam's financial stability and potential $100 billion market size highlight significant upside, but market skepticism ...